Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Ursodeoxycholic acid therapy in chronic active hepatitis.

M C Bateson1

  • 1General Hospital, Bishop Auckland, County Durham, UK.

Postgraduate Medical Journal
|September 1, 1990
PubMed
Summary

Ursodeoxycholic acid effectively treated cholestatic hepatitis in a patient experiencing steroid side effects. This treatment normalized liver enzymes and resolved steatorrhoea, offering a promising option for cholestatic liver disease.

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Change of Government and Its Effect on the NHS Hospital Outpatient Service.

Journal of the Royal College of Physicians of London·2019
Same author

Gallstones: Article was disappointing.

BMJ (Clinical research ed.)·2007
Same author

Excellent therapy for Helicobacter pylori infection.

Alimentary pharmacology & therapeutics·2006
Same author

Non-attendance at clinic: cycles of audit of a consultant based gastroenterology outpatient department.

Postgraduate medical journal·2004
Same author

Crowd pleasers.

Postgraduate medical journal·2004
Same author

Time off.

Postgraduate medical journal·2002

Area of Science:

  • Hepatology
  • Gastroenterology
  • Internal Medicine

Background:

  • Chronic active hepatitis with cholestasis presents a therapeutic challenge.
  • Long-term steroid use can lead to significant side effects, including steatorrhoea.
  • Effective management strategies for complex cholestatic liver disease are needed.